New Jersey Alliance for Clinical Translational Science: NJ ACTS

项目总结/摘要 NCATS NOSI：临床和转化科学奖（CTSA） 补充（NOT-TR-20-014），新泽西临床和转化科学联盟（NJ UL）（UL 1 TR 003017）建议在其行政团队中设立一个新职位，即质量经理 保证和质量控制。NJ质量保证和质量控制经理将 负责对提交给NCATS的CTSA相关资料、提交给ASSIST和NIH的资料进行质量审查 eRA Commons，并策划/监控整个流程，包括关键人员变更; KL 2项目;试点 涉及人或动物的项目，多样性或再进入补充学者/学员，外国成分， 竞争和行政补充，以及CTSA相关的项目和倡议，执行质量审查 向NCATS提交的CTSA相关文件，向ASSIST和NIH eRA Commons提交的文件， 目标，QA/QC经理将在NJ核心和服务之间工作，参与机构和NJ 委员会，与我们的合作伙伴学术机构和接口与NCATS和其他CTSA 财团枢纽，新的立场不仅将加强我们在新泽西州的社区提供的服务 通过直接与教师合作，建立流程和清单，并提供教育材料， 通过培训，QA/QC经理将提高向NCATS提交的事先批准的质量， 我们提交的速度，其完整性和质量，并最终改善提交的结果 国家卫生研究院和NCATS和项目。这一新职位将直接影响我们开展临床和 转化研究，为我们共同的使命做出贡献。

Project Summary/Abstract In response to NCATS NOSI: Clinical and Translational Science Award (CTSA) Program Administrative Supplements (NOT-TR-20-014), the New Jersey Alliance for Clinical and Translational Science (NJ ACTS)(UL1TR003017) propose to create a new position within its administrative team, the Manager of Quality Assurance and Quality Control. The NJ ACTS Manager for Quality Assurance and Quality Control will be responsible for quality reviews of CTSA-related submissions to NCATS, submissions to the ASSIST and NIH eRA Commons, and curate/monitor the overall process, including key personnel changes; KL2 projects; pilot projects involving human or animals, diversity or re-entry supplement scholars/trainees, foreign components, competitive and administrative supplements, and CTSA-related projects and initiatives, perform quality reviews of CTSA-related submissions to NCATS, submissions to the ASSIST and NIH eRA Commons, accomplish these goals, the QA/QC Manager will work among the NJ ACTS cores and services, participate in institutional and NJ ACTS committees, work with our partner academic institutions and interface with NCATS and other CTSA Consortium Hubs, The new position will not only enhance the services we offer within the NJ ACTS community by working directly with faculty, establishing process and checklists, and providing educational materials and training, the QA/QC Manager will improve the quality of prior approval submissions to NCATS, increasing the speed of our submissions, their completeness and quality and ultimately, improving the outcome of submissions to NIH and NCATS and program. This new position will directly impact our ability to initiate clinical and translational research, contributing to our shared mission.